Hereditary Angioedema - 10 Studies Found
| Completed |
: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2006-02-07 :
|
| Completed |
: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor : Hereditary Angioedema Types I and II : 2012-12-24 :
|
| Completed |
: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route : Hereditary Angioedema Types I and II : 2012-04-10 :
|
| Completed |
: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert : Hereditary Angioedema Types I and II : 2011-11-07 : Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection |
| Completed |
: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N :
: 2005-07-04 : Drug: C1 inhibitor concentrate |
| Completed |
: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2025-07-30 : Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC) |
| Completed |
: A Study of STAR-0215 in Participants With Hereditary Angioedema : Hereditary Angioedema : 2025-07-30 : STAR-0215 will be administered as a subcutaneous bolus injection. |
| COMPLETED |
: A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home : Hereditary Angioedema (HAE) : 2025-07-30 : No Intervention will be administered in this study. |
| COMPLETED |
: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II : Hereditary Angioedema (HAE) : 2025-07-30 |
| COMPLETED |
: A Study of STAR-0215 in Participants With Hereditary Angioedema : Hereditary Angioedema : 2025-07-30 : STAR-0215 will be administered as a subcutaneous bolus injection. |